(Q40766700)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Asghar Abdoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hoorieh Soleimanjahi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Abbas Jamali

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Parvaneh Mehrbod

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Shima Gholami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Zahra Kianmehr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Neda Feizi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Maryam Saleh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Talat Mokhtari-Azad

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mohsen Abdoli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Masoumeh Tavassoti Kheiri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

5 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

published in

Biotechnology Letters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

941-948

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Expression systems for therapeutic glycoprotein production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

CAP, a new human suspension cell line for influenza virus production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Safety of MDCK cell culture-based influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Pre- or post-pandemic influenza vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Global production capacity of seasonal influenza vaccine in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Development of high-yield influenza A virus vaccine viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Evidence for host-cell selection of influenza virus antigenic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10529-016-2069-4

10.1007/S10529-016-2069-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26945752%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference